Astera Labs, Inc. $ALAB Shares Sold by Legato Capital Management LLC

Legato Capital Management LLC decreased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 43.9% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 6,065 shares of the company’s stock after selling 4,743 shares during the quarter. Legato Capital Management LLC’s holdings in Astera Labs were worth $1,188,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ALAB. Victory Capital Management Inc. raised its holdings in Astera Labs by 320.2% in the 3rd quarter. Victory Capital Management Inc. now owns 149,796 shares of the company’s stock valued at $29,330,000 after acquiring an additional 114,145 shares during the last quarter. Sprott Inc. purchased a new stake in shares of Astera Labs in the third quarter valued at $1,136,000. Kingsview Wealth Management LLC grew its position in shares of Astera Labs by 15.8% in the third quarter. Kingsview Wealth Management LLC now owns 6,077 shares of the company’s stock valued at $1,190,000 after purchasing an additional 827 shares during the period. Geneva Partners LLC acquired a new position in Astera Labs in the third quarter valued at $1,876,000. Finally, Arete Wealth Advisors LLC lifted its position in Astera Labs by 57.0% during the third quarter. Arete Wealth Advisors LLC now owns 9,815 shares of the company’s stock worth $1,922,000 after buying an additional 3,565 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Down 8.9%

Shares of ALAB stock opened at $109.80 on Wednesday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The firm’s 50 day moving average price is $155.96 and its two-hundred day moving average price is $171.28. The stock has a market cap of $18.69 billion, a price-to-earnings ratio of 90.00, a price-to-earnings-growth ratio of 2.37 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same quarter last year, the firm posted $0.37 EPS. The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have commented on ALAB shares. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Morgan Stanley restated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a report on Wednesday, December 3rd. Royal Bank Of Canada began coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target for the company. BNP Paribas Exane began coverage on shares of Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating on the stock. Finally, Stifel Nicolaus upped their price objective on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $192.89.

Insider Activity

In other news, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer directly owned 1,452,739 shares in the company, valued at approximately $179,863,615.59. The trade was a 6.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 206,792 shares of company stock worth $25,602,869. Company insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.